Atlas Trials

Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics

Clinical trial NCT04678089 · UNKNOWN

Trial details

NCT number
NCT04678089
Sponsor
Beijing Chao Yang Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Multiple MyelomaBortezomib
Start date
2019-05-16
Primary completion
2022-12-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.